Business Standard

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

SII will also soon announce the safety data of Novavax, another indigenously developed vaccine for covid by the company.

BS Reporter New Delhi
India could start the new year with an approved Covid vaccine, the country's drug regulator indicated on Thursday even as the subject expert committee would meet on January 1 to consider three emergency-use authorisation applications including Serum Institute of India, Bharat Biotech and Pfizer-BioNtech. 

“Probably we will have a happy new year with something in hand, that’s what I can hint at,” said V G Somani, Drug Controller General of India speaking at a webinar on the science of vaccine development. 

Somani assured that processes were fast tracked by allowing parallel and seamless phase one and two trials and there

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in